医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

“3D print x craftsmanship” Achieved 200% in three days since eyewear brand “HYPHEN” has started crowdfunding by using KICKSTARTER

2022年09月28日 PM06:00
このエントリーをはてなブックマークに追加


 

TOKYO

New brand “HYPHEN“, researching and developing new structure of eyewear, by HYPHEN LTD. announced the spring 2023 model 2 series developed with the theme of luxury sports on the crowdfunding site KICKSTARTER. In three days from the September 11th, we achieved 200% of our target of 1 million yen and showed a good start.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220926005010/en/

HYPHEN (Graphic: Business Wire)

HYPHEN (Graphic: Business Wire)

- About HYPHEN -

While making use of Japanese manufacturing technology as a base, it is a brand that proposes new eyewear products that use 3D printers, which are rarely used as consumer products and combine new structure with high quality frames made with craftsmanship.

The two models “DEPART” and “TRUNKY” which are released this time are high quality eyewear with innovative new functions as eyewear for sports scenes.

- Five features of HYPHEN EYEWEAR -

1. Comfortable wearing that solves over 70% of user issues
2. The highest quality frame in eyewear history
3. Customize and personalize your attachments
4. Reduced and sustainable
5. Visibility suitable for scenes such as sports and activities

- CEO Message -

Would you like to take advantage of this wonderful success to introduce our products to the world together?
You can continue to pre-order and wholesale on KICKSTARTER. Please order early as the number of initial productions is very small. In addition, we are always looking for sales partners for release. Please contact us!

Click here for photos and videos library links

[Kickstarter project page URL (until Tuesday, October 11)]
https://bit.ly/3RVaIGL

[About us]

Company: HYPHEN LTD.

Address: 1st Floor, 2-9-14 Kiyosumi, Koto City, Tokyo 135-0024, Japan
Website: www.hyphen-tokyo.com
Contact: info@hyphen-ew.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20220926005010/en/

CONTACT

Mitsuharu Nakaya

+81-90-7495-6687

info@hyphen-ew.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Exscientia首次获得CTA核准,将启动EXS-21546治疗晚期实体瘤患者的1/2期IGNITE-AI试验
  • エクセンシア、進行性固形がん患者を対象としたEXS-21546の第1/2相試験IGNITE-AI開始のCTA承認を初めて取得
  • NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor’s TikTok Store in China and Expands Online Marketing in the U.S. and China
  • Turnstone Biologics Enters Cooperative Research and Development Agreement with the National Cancer Institute to Study TIL Therapy in Combination with Viral Immunotherapy
  • Kaneka to Manufacture and Supply Intermediates for Shionogi COVID-19 Drug